Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas

Peter J Dickinson, E. I. Surace, M. Cambell, Robert Higgins, C. M. Leutenegger, A. W. Bollen, Richard A Lecouteur, D. H. Gutmann

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Meningiomas are common primary brain tumors in dogs; however, little is known about the molecular genetic mechanisms involved in their tumorigenesis. Several tumor suppressor genes have been implicated in meningioma pathogenesis in humans, including the neurofibromatosis 2 (NF2), protein 4.1B (4.1 B), and tumor suppressor in lung cancer-1 (TSLC1) genes. We investigated the expression of these tumor suppressor genes in a series of spontaneous canine meningiomas using quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) (NF2; n 5 25) and western blotting (NF2/merlin, 4.1B, TSLC1; n 5 30). Decreased expression of 4.1B and TSLC1 expression on western blotting was seen in 6/30 (20%) and in 15/30 (50%) tumors, respectively, with 18/30 (60%) of meningiomas having decreased or absent expression of one or both proteins. NF2 gene expression assessed by western blotting and RT-PCR varied considerably between individual tumors. Complete loss of NF2 protein on western blotting was not seen, unlike 4.1B and TSLC1. Incidence of TSLC1 abnormalities was similar to that seen in human meningiomas, while perturbation of NF2 and 4.1B appeared to be less common than reported for human tumors. No association was observed between tumor grade, subtype, or location and tumor suppressor gene expression based on western blot or RT-PCR. These results suggest that loss of these tumor suppressor genes is a frequent occurrence in canine meningiomas and may be an early event in tumorigenesis in some cases. In addition, it is likely that other, as yet unidentified, genes play an important role in canine meningioma formation and growth.

Original languageEnglish (US)
Pages (from-to)884-892
Number of pages9
JournalVeterinary Pathology
Volume46
Issue number5
DOIs
StatePublished - Sep 2009

Fingerprint

Neurofibromatosis 2
tumor suppressor genes
Meningioma
lung neoplasms
Tumor Suppressor Genes
Canidae
Lung Neoplasms
neoplasms
dogs
Western Blotting
Neoplasms
Western blotting
Reverse Transcription
reverse transcriptase polymerase chain reaction
Polymerase Chain Reaction
carcinogenesis
Neurofibromatosis 2 Genes
Carcinogenesis
Neurofibromin 2
Gene Expression

Keywords

  • Brain tumor
  • Central nervous system
  • Merlin
  • Neurofibromin 2
  • Protein 4.1
  • RT-PCR
  • Schwannomin
  • Western blotting

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas. / Dickinson, Peter J; Surace, E. I.; Cambell, M.; Higgins, Robert; Leutenegger, C. M.; Bollen, A. W.; Lecouteur, Richard A; Gutmann, D. H.

In: Veterinary Pathology, Vol. 46, No. 5, 09.2009, p. 884-892.

Research output: Contribution to journalArticle

Dickinson, Peter J ; Surace, E. I. ; Cambell, M. ; Higgins, Robert ; Leutenegger, C. M. ; Bollen, A. W. ; Lecouteur, Richard A ; Gutmann, D. H. / Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas. In: Veterinary Pathology. 2009 ; Vol. 46, No. 5. pp. 884-892.
@article{afabb92b8eb74957a254aa3756cf8367,
title = "Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas",
abstract = "Meningiomas are common primary brain tumors in dogs; however, little is known about the molecular genetic mechanisms involved in their tumorigenesis. Several tumor suppressor genes have been implicated in meningioma pathogenesis in humans, including the neurofibromatosis 2 (NF2), protein 4.1B (4.1 B), and tumor suppressor in lung cancer-1 (TSLC1) genes. We investigated the expression of these tumor suppressor genes in a series of spontaneous canine meningiomas using quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) (NF2; n 5 25) and western blotting (NF2/merlin, 4.1B, TSLC1; n 5 30). Decreased expression of 4.1B and TSLC1 expression on western blotting was seen in 6/30 (20{\%}) and in 15/30 (50{\%}) tumors, respectively, with 18/30 (60{\%}) of meningiomas having decreased or absent expression of one or both proteins. NF2 gene expression assessed by western blotting and RT-PCR varied considerably between individual tumors. Complete loss of NF2 protein on western blotting was not seen, unlike 4.1B and TSLC1. Incidence of TSLC1 abnormalities was similar to that seen in human meningiomas, while perturbation of NF2 and 4.1B appeared to be less common than reported for human tumors. No association was observed between tumor grade, subtype, or location and tumor suppressor gene expression based on western blot or RT-PCR. These results suggest that loss of these tumor suppressor genes is a frequent occurrence in canine meningiomas and may be an early event in tumorigenesis in some cases. In addition, it is likely that other, as yet unidentified, genes play an important role in canine meningioma formation and growth.",
keywords = "Brain tumor, Central nervous system, Merlin, Neurofibromin 2, Protein 4.1, RT-PCR, Schwannomin, Western blotting",
author = "Dickinson, {Peter J} and Surace, {E. I.} and M. Cambell and Robert Higgins and Leutenegger, {C. M.} and Bollen, {A. W.} and Lecouteur, {Richard A} and Gutmann, {D. H.}",
year = "2009",
month = "9",
doi = "10.1354/vp.08-VP-0251-D-FL",
language = "English (US)",
volume = "46",
pages = "884--892",
journal = "Veterinary Pathology",
issn = "0300-9858",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas

AU - Dickinson, Peter J

AU - Surace, E. I.

AU - Cambell, M.

AU - Higgins, Robert

AU - Leutenegger, C. M.

AU - Bollen, A. W.

AU - Lecouteur, Richard A

AU - Gutmann, D. H.

PY - 2009/9

Y1 - 2009/9

N2 - Meningiomas are common primary brain tumors in dogs; however, little is known about the molecular genetic mechanisms involved in their tumorigenesis. Several tumor suppressor genes have been implicated in meningioma pathogenesis in humans, including the neurofibromatosis 2 (NF2), protein 4.1B (4.1 B), and tumor suppressor in lung cancer-1 (TSLC1) genes. We investigated the expression of these tumor suppressor genes in a series of spontaneous canine meningiomas using quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) (NF2; n 5 25) and western blotting (NF2/merlin, 4.1B, TSLC1; n 5 30). Decreased expression of 4.1B and TSLC1 expression on western blotting was seen in 6/30 (20%) and in 15/30 (50%) tumors, respectively, with 18/30 (60%) of meningiomas having decreased or absent expression of one or both proteins. NF2 gene expression assessed by western blotting and RT-PCR varied considerably between individual tumors. Complete loss of NF2 protein on western blotting was not seen, unlike 4.1B and TSLC1. Incidence of TSLC1 abnormalities was similar to that seen in human meningiomas, while perturbation of NF2 and 4.1B appeared to be less common than reported for human tumors. No association was observed between tumor grade, subtype, or location and tumor suppressor gene expression based on western blot or RT-PCR. These results suggest that loss of these tumor suppressor genes is a frequent occurrence in canine meningiomas and may be an early event in tumorigenesis in some cases. In addition, it is likely that other, as yet unidentified, genes play an important role in canine meningioma formation and growth.

AB - Meningiomas are common primary brain tumors in dogs; however, little is known about the molecular genetic mechanisms involved in their tumorigenesis. Several tumor suppressor genes have been implicated in meningioma pathogenesis in humans, including the neurofibromatosis 2 (NF2), protein 4.1B (4.1 B), and tumor suppressor in lung cancer-1 (TSLC1) genes. We investigated the expression of these tumor suppressor genes in a series of spontaneous canine meningiomas using quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) (NF2; n 5 25) and western blotting (NF2/merlin, 4.1B, TSLC1; n 5 30). Decreased expression of 4.1B and TSLC1 expression on western blotting was seen in 6/30 (20%) and in 15/30 (50%) tumors, respectively, with 18/30 (60%) of meningiomas having decreased or absent expression of one or both proteins. NF2 gene expression assessed by western blotting and RT-PCR varied considerably between individual tumors. Complete loss of NF2 protein on western blotting was not seen, unlike 4.1B and TSLC1. Incidence of TSLC1 abnormalities was similar to that seen in human meningiomas, while perturbation of NF2 and 4.1B appeared to be less common than reported for human tumors. No association was observed between tumor grade, subtype, or location and tumor suppressor gene expression based on western blot or RT-PCR. These results suggest that loss of these tumor suppressor genes is a frequent occurrence in canine meningiomas and may be an early event in tumorigenesis in some cases. In addition, it is likely that other, as yet unidentified, genes play an important role in canine meningioma formation and growth.

KW - Brain tumor

KW - Central nervous system

KW - Merlin

KW - Neurofibromin 2

KW - Protein 4.1

KW - RT-PCR

KW - Schwannomin

KW - Western blotting

UR - http://www.scopus.com/inward/record.url?scp=77149164822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77149164822&partnerID=8YFLogxK

U2 - 10.1354/vp.08-VP-0251-D-FL

DO - 10.1354/vp.08-VP-0251-D-FL

M3 - Article

C2 - 19429976

AN - SCOPUS:77149164822

VL - 46

SP - 884

EP - 892

JO - Veterinary Pathology

JF - Veterinary Pathology

SN - 0300-9858

IS - 5

ER -